These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6126171)

  • 41. Antidepressant pharmacotherapy of depression associated with multiple sclerosis.
    Schiffer RB; Wineman NM
    Am J Psychiatry; 1990 Nov; 147(11):1493-7. PubMed ID: 2221162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine.
    Hvizdos AJ; Bennett JA; Wells BG; Rappaport KB; Mendel SA
    Clin Pharm; 1983; 2(2):174-8. PubMed ID: 6883947
    [No Abstract]   [Full Text] [Related]  

  • 43. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
    Wilens TE; Biederman J; Baldessarini RJ; Puopolo PR; Flood JG
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):798-804. PubMed ID: 8340301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study of the mechanism of action of desipramine.
    Checkley SA; Slade AP; Shur E; Dawling S
    Br J Psychiatry; 1981 Mar; 138():248-51. PubMed ID: 6268238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-responsive symptoms in melancholia.
    Nelson JC; Mazure C; Quinlan DM; Jatlow PI
    Arch Gen Psychiatry; 1984 Jul; 41(7):663-8. PubMed ID: 6732425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thioridazine effect on desipramine plasma levels.
    Hirschowitz J; Bennett JA; Zemlan FP; Garver DL
    J Clin Psychopharmacol; 1983 Dec; 3(6):376-9. PubMed ID: 6643704
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of desipramine on clinical liver function tests.
    Price LH; Nelson JC; Jatlow PI
    Am J Psychiatry; 1984 Jun; 141(6):798-800. PubMed ID: 6731623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluoxetine inhibits desipramine metabolism.
    Wilens TE; Biederman J; Baldessarini RJ; McDermott SP; Puopolo PR; Flood JG
    Arch Gen Psychiatry; 1992 Sep; 49(9):752. PubMed ID: 1514882
    [No Abstract]   [Full Text] [Related]  

  • 53. ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine.
    Johnson A; Giuffre RM; O'Malley K
    Can J Psychiatry; 1996 Mar; 41(2):102-6. PubMed ID: 8705955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Desipramine and cutaneous reactions in pediatric outpatients.
    Biederman J; Gonzalez E; Bronstein B; De Monaco H; Wright V
    J Clin Psychiatry; 1988 May; 49(5):178-83. PubMed ID: 2966797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desipramine side-effect.
    Mosholder A; Bates C
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):1026. PubMed ID: 1757433
    [No Abstract]   [Full Text] [Related]  

  • 56. Raised serum levels of desipramine with the antiarrhythmic propafenone.
    Katz MR
    J Clin Psychiatry; 1991 Oct; 52(10):432-3. PubMed ID: 1938981
    [No Abstract]   [Full Text] [Related]  

  • 57. Characteristics of desipramine-refractory depression.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychiatry; 1994 Jan; 55(1):12-9. PubMed ID: 8294386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of desipramine on body weight in depression.
    Levitt AJ; Joffe RT; Esche I; Sherret D
    J Clin Psychiatry; 1987 Jan; 48(1):27-8. PubMed ID: 3804981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers.
    DeVane CL; Savett M; Jusko WJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):61-4. PubMed ID: 7461025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentially toxic serum concentrations of desipramine after discontinuation of valproic acid.
    Joseph AB; Wroblewski BA
    Brain Inj; 1993; 7(5):463-5. PubMed ID: 8401488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.